US biotech Cogent Biosciences closed Monday’s trading 23% higher, following the company’s announcement of positive top-line ...

Having appointed Renée Aguiar-Lucander as its chief executive in April and Maria Törnsén as chief operating officer a month ...

US CAR-T focused biotech CARGO Therapeutics today announced that it has entered into a definitive merger agreement with ...

Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also ...

Otsuka subsidiary Taiho Pharmaceuticals earlier announced that the results of a Phase III, randomized, placebo-controlled, ...

Shares of US clinical-stage biotech Apogee Therapeutics closed down 17.3% at $39.24 yesterday, despite announcing positive 16 ...

French biotech Nanobiotix’ (shares were up nearly 7% at 4.44 euros in early trading, after the company announced two important developments that aim to reinforce the global positioning of potential ...

Eli Lilly (NYSE: LLY) led the way in pharma M&A during June. The US pharma major announced two major deals in the month, both ...

The pulmonary arterial hypertension (PAH) market across the seven major markets (7MM: USA, France, Germany, Italy, Spain, UK ...

The GPRC5D-directed therapies market is witnessing robust growth, driven by high unmet need in relapsed/refractory multiple ...

Actinogen Medical (ASX: ACW), an Australian biotech, announced that the 100th participant in its pivotal XanaMIA Phase ...

Last week’s announcement of a Life Science Strategy from the European Commission, includes action to address long-standing ...